An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

673

Participants

Timeline

Start Date

October 18, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Essential Hypertension
Interventions
DRUG

Bexagliflozin

Bexagliflozin tablet, 20 mg

DRUG

Placebo

Placebo (inactive) tablet to match the active drug

Trial Locations (87)

10455

Clinical Research Site, The Bronx

10530

Clinical Research Site, Hartsdale

11230

Clinical Research Site, Brooklyn

16602

Clinical Research Site, Altoona

19040

Clinical Research Site, Hatboro

20110

Clinical Research Site, Manassas

20910

Clinical Research Site, Silver Spring

22015

Clinical Research Site, Burke

22207

Clinical Research Site, Arlington

22911

Clinical Research Site, Charlottesville

24541

Clinical Research Site, Danville

28150

Clinical Research Site, Shelby

29621

Clinical Research Site 2, Anderson

Clinical Research Site, Anderson

29650

Clinical Research Site, Greer

30030

Clinical Research Site, Decatur

30032

Clinical Research Site, Decatur

30058

Clinical Research Site, Lithonia

35205

Clinical Research Site, Birmingham

35211

Clinical Research Site, Birmingham

35242

Clinical Research Site, Birmingham

36535

Clinical Research Site, Foley

36542

Clinical Research Site, Gulf Shores

37660

Clinical Research Site, Kingsport

37909

Clinical Research Site, Knoxville

40383

Clinical Research Site, Versailles

40503

Clinical Research Site, Lexington

42003

Clinical Research Site, Paducah

43213

Clinical Research Site, Columbus

43214

Clinical Research Site, Grove City

43215

Clinical Research Site, Dublin

44124

Clinical Research Site, Lyndhurst

44311

Clinical Research Site, Akron

45236

Clinical Research Site, Cincinnati

45245

Clinical Research Site, Cincinnati

45439

Clinical Research Site, Dayton

46123

Clinical Research Site, Avon

46260

Clinical Research Site, Indianapolis

47714

Clinical Research Site, Evansville

51503

Clinical Research Site, Council Bluffs

55435

Clinical Research Site, Edina

60602

Clinical Research Site, Chicago

60611

Clinical Research Site, Chicago

60616

Clinical Research Site, Chicago

63044

Clinical Research Site, Bridgeton

63141

Clinical Research Site, St Louis

66208

Clinical Research Site, Prairie Village

70115

Clinical Research Site, New Orleans

73034

Clinical Research Site, Edmond

73119

Clinical Research Site, Oklahoma City

75093

Clinical Research Site, Plano

75143

Clinical Research Site, Mesquite

75231

Clinical Research Site, Dallas

76014

Clinical Research Site, Arlington

77070

Clinical Research Site, Houston

77339

Clinical Research Site, Kingwood

77375

Clinical Research Site, Tomball

78229

Clinical Research Site, San Antonio

80246

Clinical Research Site, Denver

80401

Clinical Research Site, Golden

80909

Clinical Research Site, Colorado Springs

80918

Clinical Research Site, Colorado Springs

84041

Clinical Research Site, Layton

84088

Clinical Research Site, West Jordan

84123

Clinical Research Site, Murray

85020

Clinical Research Site, Phoenix

85206

Clinical Research Site, Mesa

85306

Clinical Research Site, Glendale

85741

Clinical Research Site, Tucson

87102

Clinical Research Site, Albuquerque

89074

Clinical Research Site, Henderson

89128

Clinical Research Site, Las Vegas

90057

Clinical Research Site, Los Angeles

90706

Clinical Research Site, Bellflower

91776

Clinical Research Site, San Gabriel

91786

Clinical Research Site, Upland

92801

Clinical Research Site, Anaheim

93702

Clinical Research Site, Fresno

95405

Clinical Research Site, Santa Rosa

95628

Clinical Research Site, Fair Oaks

95648

Clinical Research Site, Lincoln

97239

Clinical Research Site, Portland

98405

Clinical Research Site, Tacoma

06905

Clinical Research Site, Stamford

04210

Clinical Research Site, Auburn

08611

Clinical Research Site, Trenton

02865

Clinical Research Site, Lincoln

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theracos

INDUSTRY

NCT03514641 - An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension | Biotech Hunter | Biotech Hunter